We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

54 hedge funds and large institutions have $236M invested in MorphoSys AG American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more call options, than puts

Call options by funds: $41.5M | Put options by funds: $12.5M

176% more capital invested

Capital invested by funds: $85.7M → $236M (+$150M)

133% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 9

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

26% more funds holding

Funds holding: 4354 (+11)

Holders
54
Holders Change
+11
Holders Change %
+25.58%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
23
Increased
21
Reduced
9
Closed
12
Calls
$41.5M
Puts
$12.5M
Net Calls
+$29M
Net Calls Change
+$29.2M

MOR Hedge Fund Activity: Q4 2023 in Review

54 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2023, worth a combined $236M — up 176% from $85.7M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MOR positions and 12 closed out — a net gain of 11 holders — while 21 added to existing stakes and 9 trimmed.

The largest buyer was Kynam Capital Management, opening a new position worth an estimated $31.1M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $9.23M.

  • 54 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2023, up from 43 in Q3 2023.
  • Funds reported $236M of MorphoSys AG American Depositary Shares stock for Q4 2023, up 176% quarter-over-quarter.
  • 23 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2023 and 12 closed out, a net change of +11 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q4 2023 was Kynam Capital Management, an estimated $31.1M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q4 2023 was T. Rowe Price Investment Management, an estimated $9.23M sold.

Based on aggregated 13F filings for Q4 2023.